ADAR1 Capital Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.7M | Sell |
442,615
-27,114
| -6% | -$288K | 0.72% | 33 |
|
|
2025
Q1 | $5.31M | Buy |
469,729
+65,591
| +16% | +$741K | 0.99% | 28 |
|
|
2024
Q4 | $4.24M | Hold |
404,138
| – | – | 0.85% | 28 |
|
|
2024
Q3 | $4.22M | Hold |
404,138
| – | – | 0.69% | 29 |
|
|
2024
Q2 | $4.13M | Buy |
404,138
+638
| +0.2% | +$6.52K | 0.78% | 21 |
|
|
2024
Q1 | $4.2M | Buy |
+403,500
| New | +$4.2M | 0.95% | 15 |
|